INTERNATIONAL PATENT: ETABLISSEMENT FRANCAIS DU SANG, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE DE STRASBOURG FILES APPLICATION FOR "CHIMERIC MOLECULES COMPRISING AN ANTI-FIBRIN ANTIBODY AND AN ANTITHROMBOTIC MOLECULE"

GENEVA, Dec. 29 -- ETABLISSEMENT FRANCAIS DU SANG (20 Avenue du Stade de France93210 SAINT DENIS), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101 rue de Tolbiac75013 PARIS), UNIVERSITE DE STRASBOURG (4 rue Blaise Pascal67000 STRASBOURG) filed a patent application (PCT/EP2025/067362) for "CHIMERIC MOLECULES COMPRISING AN ANTI-FIBRIN ANTIBODY AND AN ANTITHROMBOTIC MOLECULE" on Jun 20, 2025. With publication no. WO/2025/262265, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MANGIN, Pierre Henri (C/O EFS Gran...